Testing for PlGF levels can predict the risk of early-onset preeclampsia during pregnancy in people with sickle cell disease, ...
Columnist Mary Shaniqua offers up ideas for managing sickle cell disease to get the most out of busy end-of-year events.
The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback